Asia-Pacific

  • China Brief: 26 March – 1 April 2019

    April 3, 2019

    A2 Global's China Brief contains assessments of events and policies that may impact commercial interests, personnel, and assets throughout Greater China. This edition includes developments on Hong Kong's extradition law, China's launching of nationwide company inspections, and the reversal of Chinese ownership of a U.S.-based company. It also features China's import ban on a second Canadian rapeseed firm and the kidnapping of a Chinese student near Toronto.

    Read more
  • China Brief: 19-25 March 2019

    March 27, 2019

    A2 Global's China Brief contains assessments of events and policies that may impact commercial interests, personnel, and assets throughout Greater China. This edition includes strained Sino-Indian as well as Sino-Swedish relations, a chemical blast in Jiangsu province, and cases of measles in Hong Kong.

    Read more
  • China Brief: 12-18 March 2019

    March 21, 2019

    A2 Global's China Brief contains assessments of events and policies that may impact commercial interests, personnel, and assets throughout Greater China. This edition includes the Chinese cabinet's defence of policies relating to Uyghur detention camps, a collision incident on Hong Kong's Mass Transit Railway system, and protests over food safety in Chengdu.

    Read more
  • China Brief: 5-11 March 2019

    March 13, 2019

    A2 Global's China Brief contains assessments of events and policies that may impact commercial interests, personnel, and assets throughout Greater China. This edition includes developments on the National People's Congress in Beijing and the ongoing U.S. extradition of Huawei's CFO, as well as China's suspension of Boeing 737 MAX aircraft operations.

    Read more
  • China Brief: 26 February – 4 March

    March 6, 2019

    A2 Global's China Brief contains assessments of events and policies that may impact commercial interests, personnel, and assets throughout Greater China. This edition includes developments on the U.S. extradition of Huawei's CFO, China's new draft regulations for biotechnology research, and the commencement of the two sessions of the National People's Congress in Beijing.

    Read more